MDM2

MDM2 is a negative regulator of the tumor suppressor p53, and its overexpression is associated with various cancers, including sarcomas. This test helps in diagnosing tumors with MDM2 amplification, such as liposarcomas.

Also known asIhc - Mdm2 (coe) Ihc - Mdm2 (coe)

Available via

Home Collection, Lab Visit

Contains

10 parameters

Earliest reports in

3 Working Days

Test details

MDM2 Test in Vadodara Overview

Preparations

No special preparations needed

Test included
MDM2 includes 10 parameters

  • Case No
  • Specimen Type
  • Clinical Details
  • Gross Appearance
  • Microscopy
  • Impression
  • Reference
  • Comment
  • Note
  • Addendum
Frequently Asked Questions

The test detects amplification or overexpression of the MDM2 gene, often associated with liposarcomas and other tumors.

It helps differentiate benign from malignant soft tissue tumors and supports cancer diagnosis and prognosis.

Tumor tissue is obtained via biopsy and tested using FISH or molecular techniques.

MDM2 gene amplification indicates potential malignancy and helps in tumor classification.

No preparation is needed, though biopsy procedures may require fasting or other instructions.

Test code

184AR00

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Paraffin BlockOthers
SlidesSlider Mail Box

Specimen stability information

Paraffin Block, Slides

Collection instructions

Site Of Specimen/Clinical Detail/Primary Histopath Report.Mandatory If Tissue Received ,Tissue Processing Will Be Charged.

Specimen rejection criteria

Test run frequency

Every Day TIME - 18:30

Turn around time

3 Working Days

Performing locations

Department

  • Coe -histopath

CPT and Loinc codes

MDM2

2100